Holen Sie sich die Stockscreener-App
2.58
0.78%
0.0199
Handel nachbörslich:
2.62
0.04
+1.55%
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com
Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com
Sonoma Pharmaceuticals gains FDA clearance for hydrogel By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals gains FDA clearance for hydrogel - Investing.com India
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - AccessWire
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Sonoma Pharmaceuticals Inc. (SNOA) Quarterly 10-Q Report - Quartzy
Sonoma Pharmaceuticals Inc (SNOA) Quarterly 10-Q Report - Quartzy
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - AccessWire
Certain Options of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Restricted Stock Units of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Warrants of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Preferred stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - AccessWire
Sonoma Pharmaceuticals, Inc. to Exhibit At MEDICA 2024 in Dusseldorf - Marketscreener.com
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
Unveiling the Future: Animal Wound Care Market to USD 1.24 BILLION IN 2023, Forecast by 2030, Featuring a C... - WhaTech
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - AccessWire
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - AccessWire
Scar Treatment Market to See Booming Growth 2024-2031 | Bausch - openPR
Keloid Treatment Market Latest Report 2023-2031 - InsightAce Analytic
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Recent Developments in the Eye Skin Care Market - openPR
Keloid Treatment Market: Insights Predicting a $4.72 Billion Valuation by 2031 - WhaTech
Hypertrophic Scar Treatment Market Growth, Trends, and Industry Share Analysis (2024-2032) - News in Assen
Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Williams-Sonoma, Inc. (WSM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
South Korea Topical scar treatment Market Size & Outlook, 2030 - Grand View Research
Mexico Topical scar treatment Market Size & Outlook, 2030 - Grand View Research
Scar Treatment Market Top Industry Players РPerrigo Company, Smith & Nephew, Alliance Pharma, Rejûvaskin - Cauverynews
Sonoma Pharmaceuticals (SNOA) Stock Rises Amid Financial Report Insights - GuruFocus.com
Williams-Sonoma (WSM) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Scar Management Market Set to Grow at 5.61% CAGR, Projected to Reach $1.64 Billion by 2031 - WhaTech
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200-Day Moving Average of $0.56 - MarketBeat
Here's Why Williams-Sonoma (WSM) Gained But Lagged the Market Today - Yahoo Finance
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
Sonoma County will receive $43 million in opioid settlements. How should it be spent? - The Santa Rosa Press Democrat
SONO’s latest rating updates from top analysts. - Knox Daily
Top investors say Sonos Inc (SONO) ticks everything they need - SETE News
15,500 Shares in Sonoco Products (NYSE:SON) Acquired by Skandinaviska Enskilda Banken AB publ - Defense World
Federated Hermes Inc. Sells 466 Shares of Sonoco Products (NYSE:SON) - Defense World
Intubation Tubes Market Report Details Growth Drivers, Opportunities, Share Report And Forecast To 2033 - WhaTech
Hypertrophic And Keloid Scar Treatment Market Advancements Highlighted by Size, Growth,Outlook Report 2033 - WhaTech
Scar Treatment Global Market Report 2024: Growth Drivers and Dynamics 2033 - WhaTech
Sei Investments Co. Has $75.60 Million Position in Sonoco Products (NYSE:SON) - Defense World
Ameritas Investment Partners Inc. Reduces Stock Position in Sonoco Products (NYSE:SON) - Defense World
Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule - MSN
AE Wealth Management LLC Buys 12,401 Shares of Sonoco Products (NYSE:SON) - Defense World
Richardson Financial Services Inc. Sells 1,295 Shares of Sonoco Products (NYSE:SON) - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):